Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
695
datasets available to search
ShareScore release 0.9.0
Dataset results
695 results for “chronic hepatitis C”
Safety and PK Study of MP-424 to Treat Chronic Hepatitis C
ClinicalTrials.gov study NCT00591214. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Sofosbuvir/Velpatasvir Fixed Dose Combination in Participants With Chronic Hepatitis C Virus Infection Who Have Received a Liver Transplant
ClinicalTrials.gov study NCT02781571. IPD Sharing: YES. Countries: 3. Publications: 1.
Treatment of Chronic Hepatitis C During Pregnancy With Sofosbuvir/Velpatasvir
ClinicalTrials.gov study NCT04382404. IPD Sharing: YES. Countries: 1. Publications: 7.
TMC435HPC3001 - An Efficacy, Safety and Tolerability Study for TMC435 vs Telaprevir in Combination With PegINFα-2a and Ribavirin in Chronic Hepatitis C Patients Who Were Null or Partial Responders to
ClinicalTrials.gov study NCT01485991. IPD Sharing: Not stated. Countries: 24. Publications: 1.
Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)
ClinicalTrials.gov study NCT02503735. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Community-based Treatment of Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia
ClinicalTrials.gov study NCT02339038. IPD Sharing: NO. Countries: 1. Publications: 4.
Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced
ClinicalTrials.gov study NCT00793793. IPD Sharing: Not stated. Countries: 4. Publications: 2.
High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1
ClinicalTrials.gov study NCT00735969. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Elbasvir (EBR)/Grazoprevir (GZR) in Pediatric Participants With Chronic Hepatitis C Infection (MK-5172-079)
ClinicalTrials.gov study NCT03379506. IPD Sharing: YES. Countries: 4. Publications: 1.
An Observational Study of Pegasys (Peginterferon Alfa-2a) Plus Copegus (Ribavirin) in Participants With Chronic Hepatitis C (CHC), Genotype 2, 3, 1 or 4, Undergoing Opioid Maintenance Therapy
ClinicalTrials.gov study NCT01416610. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of MP-424, Peginterferon Alfa-2b, and Ribavirin in Patients With Chronic Hepatitis C Who Relapsed After Previous Interferon Based Therapy
ClinicalTrials.gov study NCT00780910. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection
ClinicalTrials.gov study NCT03067129. IPD Sharing: YES. Countries: 9. Publications: 2.
Comparative Efficacy of Fixed-dose Combination Sofosbuvir + Ledipasvir, 8 vs. 12 Weeks in Chronic Hepatitis C Genotype 6
ClinicalTrials.gov study NCT02480166. IPD Sharing: Not stated. Countries: 1. Publications: 5.
A Registry for Participants With Cirrhosis Who Achieve a Sustained Virologic Response Following Treatment With a Sofosbuvir-Based Regimen Without Interferon for Chronic Hepatitis C Infection
ClinicalTrials.gov study NCT02292706. IPD Sharing: YES. Countries: 10. Publications: 2.
PROPHESYS 2: An Observational Study on Predictors of Response in Treatment-naïve Patients With Chronic Hepatitis C Treated With Pegasys (Peginterferon Alfa-2a) or Peginterferon-alfa-2b
ClinicalTrials.gov study NCT01066793. IPD Sharing: Not stated. Countries: 4. Publications: 2.
Efficacy of Nitazoxanide in the Treatment of Chronic Hepatitis C Virus (HCV)
ClinicalTrials.gov study NCT01276756. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease
ClinicalTrials.gov study NCT00028093. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection
ClinicalTrials.gov study NCT02250807. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Latino Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) and COPEGUS (Ribavirin) in Treatment-Naive Patients With Chronic Hepatitis C-Genotype 1.
ClinicalTrials.gov study NCT00107653. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Phase 1 Study To Evaluate Antiviral Activity Of Small Molecule Direct Antiviral Agent At Multiple Doses In Subjects With Chronically Infected Hepatitis C Virus.
ClinicalTrials.gov study NCT00671671. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.